Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden
暂无分享,去创建一个
Joanna M. Wardlaw | Fergus N. Doubal | J. Wardlaw | F. Doubal | M. Dennis | J. Staals | S. Makin | Stephen D.J. Makin | Julie Staals | Martin S. Dennis | Stephen D. Makin
[1] Lenore J Launer,et al. Epidemiology of White Matter Lesions , 2004, Topics in magnetic resonance imaging : TMRI.
[2] M. Dichgans,et al. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.
[3] J. Staals,et al. Accumulation of MRI Markers of Cerebral Small Vessel Disease is Associated with Decreased Cognitive Function. A Study in First-Ever Lacunar Stroke and Hypertensive Patients , 2013, Front. Aging Neurosci..
[4] R. Rouhl,et al. Ambulatory Blood Pressure in Patients With Lacunar Stroke: Association With Total MRI Burden of Cerebral Small Vessel Disease , 2013, Stroke.
[5] W. Mali,et al. White Matter Lesions and Brain Atrophy: More than Shared Risk Factors? A Systematic Review , 2009, Cerebrovascular Diseases.
[6] F. Fazekas,et al. Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.
[7] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[8] P. Sandercock,et al. Is it a Vascular Event and Where is the Lesion?: Identifying and Interpreting the Symptoms and Signs of Cerebrovascular Disease , 2008 .
[9] C. Sudlow,et al. Differences Between Ischemic Stroke Subtypes in Vascular Outcomes Support a Distinct Lacunar Ischemic Stroke Arteriopathy: A Prospective, Hospital-Based Study , 2009, Stroke.
[10] C. Sudlow,et al. Differing Risk Factor Profiles of Ischemic Stroke Subtypes: Evidence for a Distinct Lacunar Arteriopathy? , 2010, Stroke.
[11] Joanna M Wardlaw,et al. Improving Interrater Agreement About Brain Microbleeds: Development of the Brain Observer MicroBleed Scale (BOMBS) , 2009, Stroke.
[12] D. Norris,et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. , 2011, Brain : a journal of neurology.
[13] Aad van der Lugt,et al. Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study , 2010, Stroke.
[14] Steven Warach,et al. Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .
[15] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[16] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[17] H. Chabriat,et al. Cerebral Atrophy in Cerebrovascular Disorders , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[18] Jeffrey L. Saver,et al. Cerebral White Matter Hyperintensities on MRI: Current Concepts and Therapeutic Implications , 2006, Cerebrovascular Diseases.
[19] Henri A. Vrooman,et al. Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.
[20] Hugh S Markus,et al. Brain Atrophy and Cerebral Small Vessel Disease: A Prospective Follow-Up Study , 2011, Stroke.
[21] Joanna M. Wardlaw,et al. Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936 , 2012, European Radiology.
[22] H. Markus,et al. Magnetic Resonance Imaging in Cerebral Small Vessel Disease and its Use as a Surrogate Disease Marker , 2011, International journal of stroke : official journal of the International Stroke Society.
[23] P. A. Armitage,et al. Development and initial testing of normal reference MR images for the brain at ages 65–70 and 75–80 years , 2008, European Radiology.
[24] M. Välimäki,et al. Manifestation, Management and Molecular Analysis of Candidate Genes in Two Rare Cases of Thyrotoxic Hypokalemic Periodic Paralysis , 2005, Hormone Research in Paediatrics.
[25] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[26] D. Leys,et al. Intracranial arterial dolichoectasia and small‐vessel disease in stroke patients , 2005, Annals of neurology.
[27] J. Bamford,et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.
[28] P. Scheltens,et al. The renin-angiotensin-aldosterone system in cerebral small vessel disease , 2008, Journal of Neurology.
[29] L. Fried,et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.
[30] P. Scheltens,et al. 2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? , 2011, Cerebrovascular Diseases.
[31] Karen J. Ferguson,et al. Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.
[32] C. Sudlow,et al. Associations of Clinical Stroke Misclassification (‘Clinical-Imaging Dissociation’) in Acute Ischemic Stroke , 2010, Cerebrovascular Diseases.
[33] A. Hofman,et al. Assessment of cerebral small vessel disease predicts individual stroke risk , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[34] P. Koudstaal,et al. Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.